🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07044531
Recruiting Not applicable

DEVELOPMENT OF A NOVEL PEER RECOVERY SUPPORTER TRAINING PLATFORM

NCT07044531 · tracked via the Priya Life Science USA tracker
Sponsor
Thrive Digital Health, LLC
Phase
Not applicable
Started
2025-05-07
Last updated
2025-07-22

Condition(s) studied

Substance Use DisordersAlcohol Use DisordersRecovery Support ServicesPeer Recovery Coaching

Investigational drug(s) / intervention(s)

Training-as-Usual (TAU)TDPP-A (Asynchronous Platform)TDPP-Z (Asynchronous + Zoom)

Training-as-Usual (TAU): Participants receive the standard Peer Recovery Supporter (PRS) training currently offered by CCAR. This training follows existing certification requirements and does not include any digital modules or facilitated teleconferencing components.

TDPP-A (Asynchronous Platform): Participants engage with the Thrive Digital Peer Platform (TDPP), a fully asynchronous, self-paced online training program. The content includes 11 interactive modules structured using the Connect → Grow → Apply (CGA) learning framework, featuring peer stories, behavioral exercises, and scenario-based assessments.

TDPP-Z (Asynchronous + Zoom): Participants use the same asynchronous TDPP platform as the TDPP-A group, with the addition of three live, facilitator-led Zoom sessions. These synchronous group sessions provide opportunities for applied learning, discussion, and skill reinforcement.

Study summary

The focus of this study is to assess the effect on Peer Recovery Support Service providers of the fully asynchronous training platform (TDPP) and the TDPP with live zoom sessions on skill and adherence compared with training-as-usual.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: Eligible participants will be prospective PRSS providers residing in the U.S., ages 18 and over, with at least one year of continuous sobriety. \- Exclusion Criteria: We will exclude individuals with eligibility questionnaire responses indicating: (a) an inability to read or speak English; (b) active suicidal ideation (PHQ-9, Item 9); (c) severe anxiety (GAD-7 \>15); (d) significant medical illnesses, and; (e) unable to complete the baseline assessment or unavailable for computer and telephone follow-ups over the approximately ten month study period. \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Thrive Digital Health Solon Ohio Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07044531 on ClinicalTrials.gov ↗ ← All trials in the USA